Latest Breaking News On - Agios pharmaceuticals - Page 6 : comparemela.com

The Goldman Sachs Group Increases Agios Pharmaceuticals (NASDAQ:AGIO) Price Target to $33 00

Agios Pharmaceuticals (NASDAQ:AGIO – Free Report) had its target price raised by The Goldman Sachs Group from $29.00 to $33.00 in a report issued on Friday morning, Benzinga reports. The firm currently has a neutral rating on the biopharmaceutical company’s stock. Several other research analysts have also commented on AGIO. JPMorgan Chase & Co. reduced […]

United statesJacqualyna fouseZurcher kantonalbank zurich cantonalbankJames william burnsSecurities exchange commissionMirae asset global investments coHedge funds weigh in on agios pharmaceuticalsNews ratings for agios pharmaceuticals dailyRoyal bankGoldman sachs groupCantor fitzgeraldAgios pharmaceuticals stock performanceAgios pharmaceuticalsJpmorgan chase coChina universal asset management coAgios pharmaceuticals inc

Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 14, 2024

Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 14, 2024
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United kingdomDan budwickChris taylorAgios pharmaceuticalsCorporate communicationsAgios pharmaceuticals incMarkets global healthcare conferenceInvestor relations

The Goldman Sachs Group Increases Agios Pharmaceuticals (NASDAQ:AGIO) Price Target to $33 00

Agios Pharmaceuticals (NASDAQ:AGIO – Get Free Report) had its price target hoisted by equities researchers at The Goldman Sachs Group from $29.00 to $33.00 in a report released on Friday, Benzinga reports. The brokerage presently has a “neutral” rating on the biopharmaceutical company’s stock. The Goldman Sachs Group’s price target indicates a potential downside of […]

United statesJames william burnsBrian goffGoldman sachs groupAgios pharmaceuticals incAgios pharmaceuticals stock performanceMirae asset global investments coSecurities exchange commissionOak ridge investmentsCantor fitzgeraldRoyal bankChina universal asset management coNews ratings for agios pharmaceuticals dailyJpmorgan chase coAgios pharmaceuticalsInstitutional trading of agios pharmaceuticals

Investment Analysts Price Target Changes for May 3rd (AAPL, AC, ACHC, ACLS, ACO X, ACQ, AEP, AFL, AGCO, AGIO)

Investment Analysts’ price target changes for Friday, May 3rd: Apple (NASDAQ:AAPL) had its target price increased by Monness Crespi & Hardt from $200.00 to $205.00. The firm currently has a buy rating on the stock. Apple (NASDAQ:AAPL) had its target price boosted by JPMorgan Chase & Co. from $210.00 to $225.00. They currently have an […]

United statesNew yorkRoth mkmRobertw bairdCraig hallumStifel nicolausPiper sandlerAscendis pharmaRaymond jamesQuanta servicesSpecialty insurance groupPennon groupAmerant bancorpHanover insurance groupHudbay mineralsNational bankshares inc

The Goldman Sachs Group Boosts Agios Pharmaceuticals (NASDAQ:AGIO) Price Target to $33 00

Agios Pharmaceuticals (NASDAQ:AGIO – Get Free Report) had its price target upped by The Goldman Sachs Group from $29.00 to $33.00 in a research report issued on Friday, Benzinga reports. The firm currently has a “neutral” rating on the biopharmaceutical company’s stock. The Goldman Sachs Group’s target price suggests a potential downside of 4.29% from […]

United statesJames william burnsZurcher kantonalbank zurich cantonalbankJacqualyna fouseGoldman sachs groupAgios pharmaceuticals incMirae asset global investments coSecurities exchange commissionCantor fitzgeraldAgios pharmaceuticals price performanceRoyal bankNews ratings for agios pharmaceuticals dailyJpmorgan chase coInstitutional trading of agios pharmaceuticalsTd asset management incSg americas securities